Portal de Periódicos da CAPES

Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types

2021; American Medical Association; Volume: 2; Issue: 12 Linguagem: Inglês

10.1001/jamahealthforum.2021.4205

2689-0186

Sri Lekha Tummalapalli, Julio Lamprea Montealegre, Neil D. Warnock, Michael Green, Said A. Ibrahim, Michelle M. Estrella,

Potassium and Related Disorders

This cross-sectional study evaluates the stipulations of coverage under commercial, health insurance exchange, Veterans Affairs, Medicare, Medicaid, or other insurance for canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.